Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bivinal
- Development stage
- Unknown
- Lead developer
- Square Pharmaceuticals
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral, Intramuscular, Intravenous
01
Overview
Bivinal is a multi-vitamin formulation composed of essential B-complex vitamins, typically including Thiamine (B1), Riboflavin (B2), Pyridoxine (B6), and Nicotinamide (B3), with some formulations also containing Cyanocobalamin (B12) and Calcium Pantothenate (B5). These vitamins function as vital coenzymes in a wide array of metabolic processes. Thiamine is essential for carbohydrate metabolism and neural function; Riboflavin is a precursor for FAD and FMN, which are critical for electron transport; Pyridoxine is involved in amino acid metabolism and neurotransmitter synthesis; and Nicotinamide is a precursor for NAD and NADP, essential for cellular energy production. Bivinal is primarily indicated for the prevention and treatment of Vitamin B deficiency syndromes, such as beriberi, peripheral neuropathy, and glossitis, and is used as supportive therapy in conditions of increased nutritional demand or impaired absorption.
- Brand names
- BivinalBivinal Forte
- Other names
- Vitamin B-complex
Beyond the preview
Go deeper on Bivinal.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bivinal.